Palliative Care
Read full paper →- Authors
- Michael H Levy, Anthony L. Back, Costantino Benedetti, J Andrew Billings, Susan Block, Barry Boston, Eduardo Bruera, Sydney Dy, Catherine Eberle, Kathleen M Foley, Sloan Beth Karver, Sara J. Knight, Sumathi Misra, Christine S Ritchie, David Spiegel, L Sutton, Susan G. Urba, Jamie H. Von Roenn, Sharon M. Weinstein
- Journal
- Journal of the National Comprehensive Cancer Network
- Year
- 2009
- Citations
- 301
Abstract
Category 1: The recommendation is based on high-level evidence (e.g., randomized controlled trials) and there is uniform NCCN consensus. Category 2A: The recommendation is based on lowerlevel evidence and there is uniform NCCN consensus. Category 2B: The recommendation is based on lowerlevel evidence and there is nonuniform NCCN consensus (but no major disagreement). Category 3: The recommendation is based on any level of evidence but reflects major disagreement. All recommendations are category 2A unless otherwise noted. Clinical trials: The NCCN believes that the best management for any cancer patient is in a clinical trial. Participation in clinical trials is especially encouraged.